Patricia Brubaker is Professor Emerita in the Departments of Physiology and Medicine at the University of Toronto. She is recognized internationally for her innovative research to characterize the secretion and function of the intestinal hormones, glucagon-like peptide (GLP)-1 and GLP-2. Her studies have contributed to the development of novel treatments for patients with Type 2 diabetes and obesity, conditions that affect millions of Canadians, as well as for rare individuals with intestinal failure. She has been honoured with ‘Lifetime Achievement Awards’ from Diabetes Canada and the Canadian Physiological Society and is widely sought out by industry for her expertise.